臨床試驗材料和耗材市場規模、佔有率、成長分析，按服務、按階段、按類型、按治療領域、按地區 - 行業預測，2025-2032

2023年臨床試驗材料和耗材的全球市場規模預計為35億美元，從2024年的38.4億美元成長到2032年的81.2億美元，在預測期內（2025-2032年）預計將以2018 年年複合成長率為9.8%）。

管理臨床試驗用品對於避免缺貨和生產過剩等問題至關重要，尤其是在藥物檢測成本增加的情況下。有效的供應鏈管理對於臨床研究至關重要，並且必須解決基礎設施限制和嚴格的法規。主要市場促進因素包括臨床試驗的擴展和複雜性。臨床試驗用品包括輸液幫浦、霧化器、針頭等多種設備，對於心血管、神經、腫瘤、肺部領域疾病的評估和治療至關重要。藥物開發商和製造商擴大外包耗材，以確保及時交付到臨床實驗試驗場所。此外，技術進步、解決方案提供者的策略性成長以及專利到期日的增加都刺激了對臨床試驗材料的需求，並促進了市場的強勁成長。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 宏觀經濟指標
• 價值鏈分析
• 價格分析
• 供應鏈分析
• 技術分析
• 監管分析

臨床試驗材料與耗材市場規模：依服務分類

• 市場概況
• 物流/配送
• 儲存和保留
• 包裝標籤百葉窗
• 製造業
• 比較採購
• 其他服務

臨床試驗材料與耗材市場規模：依階段

• 市場概況
• 第一階段
• 第二階段
• 第三階段
• 第四階段
• 學士/工學士研究

臨床試驗材料和耗材市場規模：按類型

• 市場概況
• 小分子
• 生物製藥
• 醫療設備

臨床試驗材料與耗材市場規模：依治療領域

• 市場概況
• 腫瘤學
• 感染疾病
• 神經病學
• 代謝紊亂
• 免疫學
• 心臟病學
• 遺傳疾病
• 其他治療領域

臨床試驗材料和耗材市場規模：按最終用戶分類

• 市場概況
• 製藥和生物技術公司
• 合約研究組織（CRO）
• 醫療設備公司

臨床試驗材料及耗材市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
• 收益與前一年同期比較（2022-2024）

主要企業簡介

• Lonza Group
• Catalent, Inc.
• Piramal Pharma Solutions
• Almac Group
• Parexel International
• Eurofins Scientific
• Marken（A Subsidiary of UPS）
• Thermo Fisher Scientific, Inc.
• Sharp Services, LLC
• PCI Pharma Services
• Nuvisan
• Celerion
• WuXi AppTec
• Recipharm AB
• Tunnell Consulting
• Aesica Pharmaceuticals
• Boehringer Ingelheim
• Kendle International（Now a part of INC Research）
• Syneos Health
• Vetter Pharma

結論和建議

Global Clinical Trial Materials And Supplies Market size was valued at USD 3.5 billion in 2023 and is poised to grow from USD 3.84 billion in 2024 to USD 8.12 billion by 2032, growing at a CAGR of 9.8% during the forecast period (2025-2032).

The management of clinical trial supplies is critical to avert issues such as inventory expiration and overproduction, especially as drug detection costs rise. Effective supply chain management is essential in clinical research, addressing infrastructure limitations and stringent regulations. Key market drivers include the expansion and growing complexity of clinical trials. Clinical trial supplies encompass various instruments like infusion pumps, nebulizers, and syringe needles, pivotal for evaluating and treating diseases across cardiovascular, neurological, oncological, and pulmonary fields. Outsourcing of supplies by drug developers and manufacturers is increasing, ensuring timely delivery to investigator sites. Additionally, technological advancements, strategic growth among solution providers, and a rise in patent expirations have fueled demand for clinical trial materials, contributing to robust market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Clinical Trial Materials And Supplies market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Clinical Trial Materials And Supplies Market Segmental Analysis

Global Clinical Trial Materials And Supplies Market is segmented by service, phase, type, therapeutic area, end user and region. Based on service, the market is segmented into logistics & distribution, storage & retention, packaging, labelling & blinding, manufacturing, comparator sourcing and other services. Based on phase, the market is segmented into Phase I, Phase II, Phase III, Phase IV, BA/BE Studies. Based on type, the market is segmented into small-molecules, biologic drugs and medical devices. Based on therapeutic area, the market is segmented into oncology, infectious diseases, neurology, metabolic disorders, immunology, cardiology, genetic diseases and other therapeutic areas. Based on end user, the market is segmented into pharmaceutical and biotechnology companies, contract research organisations (CRO's) and medical device companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Clinical Trial Materials And Supplies Market

The Global Clinical Trial Materials and Supplies market is significantly driven by the increasing participation of patients in clinical trials within emerging economies such as China, India, and South Korea. The lower costs associated with conducting clinical trials in these nations-28% cheaper before tax incentives and a remarkable 60% less expensive after tax incentives compared to the United States-have attracted pharmaceutical companies seeking to optimize their research expenditures. This trend has also led to a shift in clinical trial locations, particularly for rare diseases. Furthermore, advancements in technology and data analytics contribute to improved decision-making in clinical trials, prompting the pharma and biotech sectors to invest in outsourcing innovative solutions that enhance trial processes and supply chains in these developing markets.

Restraints in the Global Clinical Trial Materials And Supplies Market

The Global Clinical Trial Materials and Supplies market faces considerable restraints primarily due to the high attrition rates of drug candidates during development, which lead to immense research and development costs. The complexities associated with R&D for rare diseases often require specialized personnel to conduct clinical trials, further complicating the process. For instance, only 7 out of 100 cancer drugs that reach clinical trials ultimately gain regulatory approval, with most drug candidates failing before this stage. Additionally, the entire journey from drug discovery to FDA approval can span 10-15 years and incur costs around USD 2.6 billion, with less than 12% of candidates reaching Phase clinical trials successfully, posing significant challenges to market expansion.

Market Trends of the Global Clinical Trial Materials And Supplies Market

The Global Clinical Trial Materials and Supplies market is witnessing a notable trend towards the increased utilization of biologics and temperature-sensitive medications, with approximately 35% of late-phase pharmaceutical drugs classified as biologics, alongside 38% being temperature-sensitive. This shift is largely attributed to the advantages biologics offer, including fewer side effects compared to traditional pharmaceuticals. With the expectation that the prevalence of biologics will continue to rise, there is a corresponding surge in demand for advanced cold chain logistics and storage solutions to ensure the efficacy and safety of these sensitive materials during clinical trials, thereby shaping the future landscape of the market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Supply Chain Analysis
• Technology Analysis
• Regulatory Analysis

Global Clinical Trial Materials And Supplies Market Size by Service & CAGR (2025-2032)

• Market Overview
• Logistics & Distribution
• Storage & Retention
• Packaging, Labelling & Blinding
• Manufacturing
• Comparator Sourcing
• Other Services

Global Clinical Trial Materials And Supplies Market Size by Phase & CAGR (2025-2032)

• Market Overview
• Phase I
• Phase II
• Phase III
• Phase IV
• BA/BE Studies

Global Clinical Trial Materials And Supplies Market Size by Type & CAGR (2025-2032)

• Market Overview
• Small-Molecules
• Biologic Drugs
• Medical Devices

Global Clinical Trial Materials And Supplies Market Size by Therapeutic Area & CAGR (2025-2032)

• Market Overview
• Oncology
• Infectious Diseases
• Neurology
• Metabolic Disorders
• Immunology
• Cardiology
• Genetic Diseases
• Other Therapeutic Areas

Global Clinical Trial Materials And Supplies Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical And Biotechnology Companies
• Contract Research Organisations (CRO's)
• Medical Device Companies

Global Clinical Trial Materials And Supplies Market Size & CAGR (2025-2032)

• North America (Service, Phase, Type, Therapeutic Area, End User)
  • US
  • Canada
• Europe (Service, Phase, Type, Therapeutic Area, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Service, Phase, Type, Therapeutic Area, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Service, Phase, Type, Therapeutic Area, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Service, Phase, Type, Therapeutic Area, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
• Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Lonza Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Catalent, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Piramal Pharma Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Almac Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parexel International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Marken (A Subsidiary of UPS)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sharp Services, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PCI Pharma Services
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nuvisan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celerion
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Recipharm AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tunnell Consulting
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aesica Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kendle International (Now a part of INC Research)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syneos Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetter Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations